Testing New Biomarkers for Acute Kidney Injury: Association, Prediction, and Intervention

American Journal of Kidney Diseases

Volumn 54, Issue 6, 2009, Pages 987-989

  Parikh, Chirag R ^a   Garg, Amit X ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY INJURY; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DEATH; DIALYSIS; DISEASE ASSOCIATION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY INJURY; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROTEIN BLOOD LEVEL; SHORT COURSE THERAPY;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CREATININE; HUMANS; KIDNEY FAILURE, ACUTE; LIPOCALINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 70449641064     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.10.004     Document Type: Editorial

References (3)

1. American Society of Nephrology. American Society of Nephrology renal research report. J Am Soc Nephrol 16 7 (2005) 1886-1903
2. Haase M., Bellomo R., Devarajan P., et al., NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 54 6 (2009) 1012-1024
3. Bolignano D., Lacquaniti A., Coppolino G., et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4 2 (2009) 337-344